Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sex Disparities in Hypoxic Vasodilation and Impact of Obesity
NCT05219799Phase 1Recruiting
- Sponsor
- University of Missouri
- Start
- Mar 2023
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of propranolol, isoprenaline, phentolamine and norepinephrine, sponsored by University of Missouri. Primary endpoint: Change in forearm vascular conductance. Started Mar 2023; status: recruiting.
02
Drugs
propranololisoprenalinephentolaminenorepinephrine
Beyond the preview
Go deeper on NCT05219799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05219799.